WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 11 fonti

Race to develop ebola vaccines is ON: Three jabs in development

Experts have warned that the spread, caused by the Bundibugyo strain of the virus, could surpass the infamous outbreak of Ebola which killed more than 11,000 people between 2014 and 2016.

Raccontata daindependent.co.ukeuronews.comthenationalnews.comvanguardngr.comabc.net.aunewsbytesapp.comdailymail.comgulfnews.comnpr.orgaljazeera.comtheguardian.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
dailymail.comStai leggendo1 mesi fa

Race to develop ebola vaccines is ON: Three jabs in development

Experts have warned that the spread, caused by the Bundibugyo strain of the virus, could surpass the infamous outbreak of Ebola which killed more than 11,000 people between 2014 and 2016.

originale
abc.net.au1 mesi fa

Race to develop Ebola vaccine as deadly strain of virus spreads

Bundibugyo Ebola outbreak (250+ deaths, 1,100+ infected) accelerates vaccine development via three modular platforms (rVSV, ChAdOx1, mRNA) backed by IAVI, CEPI ($50M), Gavi ($50M) with 2-9 month timelines. Model of rapid iteration and manufacturing scale-up using existing biotech infrastructure during health crises.

Leggi questa versione → originale
gulfnews.com1 mesi fa

Race to develop Ebola vaccine heats up

Global health groups race to develop a Bundibugyo Ebola vaccine as cases surge in DR Congo and Uganda, with WHO backing a leading rVSV candidate.

Leggi questa versione → originale
vanguardngr.com1 mesi fa

'We need to act now': Race to develop Ebola vaccine heats up

Non-profits accelerated vaccine development for Bundibugyo strain; WHO backed rVSV platform, CEPI committed $3.2M to fast-track candidates. Crisis-coordinated nonprofit-academia-pharma response demonstrates governance models for tech leaders scaling distributed R&D teams under urgency.

Leggi questa versione → originale
newsbytesapp.com1 mesi fa

3 Ebola vaccines being developed amid outbreak in Africa

Three vaccines are being developed to address a rare Ebola strain, which has already claimed nearly 250 lives and poses the risk of becoming the worst outbreak recorded.

Leggi questa versione → originale
theguardian.com1 mesi fa

The race to combat Ebola: what vaccines and treatments are being developed and how long will it take?

With the Bundibugyo strain of the disease spreading across the DRC and Uganda, scientists and researchers are trying to find rapid solutions

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 1 giugno 2026·independent.co.uk

    Moderna receives $50 million to develop Ebola vaccine as number of cases surge

    This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has seen over 900 suspected cases and more than 220…

  2. lunedì 1 giugno 2026·euronews.com

    Health body fast-tracks three Ebola vaccines as virus continues spread

    Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.

  3. lunedì 1 giugno 2026·thenationalnews.com

    Race for Ebola vaccine gets $50m boost as medics struggle to trace contacts | The National

    Four nurses discharged from DR Congo hospital after recovering from virus

  4. lunedì 1 giugno 2026·vanguardngr.com

    'We need to act now': Race to develop Ebola vaccine heats up

    While it marks the 17th Ebola outbreak in the DRC, it is just the third caused by the Bundibugyo strain, for which there are no...

  5. lunedì 1 giugno 2026·abc.net.au

    Race to develop Ebola vaccine as deadly strain of virus spreads

    Nearly 250 people are suspected to have died, and more than 1,100 are infected with the rare strain of Ebola in the DRC and Uganda, though the true spread of the virus is feared…

  6. martedì 2 giugno 2026·newsbytesapp.com

    3 Ebola vaccines being developed amid outbreak in Africa

    Three vaccines are being developed to address a rare Ebola strain, which has already claimed nearly 250 lives and poses the risk of becoming the worst outbreak recorded.

  7. martedì 2 giugno 2026·dailymail.com

    Race to develop ebola vaccines is ON: Three jabs in development

    Experts have warned that the spread, caused by the Bundibugyo strain of the virus, could surpass the infamous outbreak of Ebola which killed more than 11,000 people between 2014…

  8. martedì 2 giugno 2026·gulfnews.com

    Race to develop Ebola vaccine heats up

    Global health groups race to develop a Bundibugyo Ebola vaccine as cases surge in DR Congo and Uganda, with WHO backing a leading rVSV candidate.

  9. giovedì 4 giugno 2026·npr.org

    What will it take to get a vaccine for the Ebola strain driving the current outbreak?

    There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo. Trials are going on for several candidates. How long will…

  10. giovedì 4 giugno 2026·aljazeera.com

    What are the Ebola vaccines under research, and when will they be ready?

    At least three vaccines are being funded, research being fast-tracked as the outbreak spreads faster than the response.

  11. giovedì 4 giugno 2026·theguardian.com

    The race to combat Ebola: what vaccines and treatments are being developed and how long will it take?

    With the Bundibugyo strain of the disease spreading across the DRC and Uganda, scientists and researchers are trying to find rapid solutions

  12. giovedì 4 giugno 2026·independent.co.uk

    We talked to two scientists racing to find a new Ebola vaccine. Here’s what to know

    The Oxford group is using ChADOx1, a viral-vector platform that formed the basis of the Oxford-AstraZeneca COVID-19 vaccine